Targeted therapy and radiation synergize in pediatric high-grade glioma

Research at St. Jude recently showed that the drug capmatinib is effective at crossing the blood-brain-barrier, synergizing with radiation to effectively treat pediatric high-grade glioma.

Read more: https://www.stjude.org/research/progress/2024/like-kismet-targeted-therapy-and-radiation-synergize-in-pediatric-high-grade-glioma.html